openPR Logo
Press release

Hemoglobinopathies Market – Industry Analysis, Share, Research Report 2023

03-21-2017 07:56 AM CET | Health & Medicine

Press release from: Global Market Insights, Inc.

Global Market Insights, Inc.

Global Market Insights, Inc.

Hemoglobinopathies Market size is driven by high occurrence in underdeveloped nations such as Arab nations, Sub-Saharan region and South East Asia. Hemoglobinopathies Market size was valued at over USD 4 billion in 2015.

Other key reasons for disease prevalence include lack of patient awareness, unmet needs for treatment, and absence of permanent cure. Lack of awareness for treatment and diagnosis of such rare diseases generates huge untouched opportunities in the industry. The hemoglobinopathies market is anticipated to grow on a global scale owing to improving health care infrastructure.

Request for an in-depth table of contents for this report @

Hemoglobinopathy is a group of inherited disorders caused due to abnormal production or aberration in hemoglobin structure. Different disorders comprise sickle cell anemia, S-C and hemoglobin C disorder and various forms of thalassemia. Originally found in the Mediterranean area and large parts of Asia and Africa, they now have presence across the globe on account of growing migration.

Most common tools/tests for diagnosis of hemoglobinopathies and thalassemia disorders are pre-implantation genetic diagnosis, genetic and blood testing, alkaline and acid gel electrophoresis, hemoglobin electrophoresis, prenatal genetic testing and HbA2 quantification by ion exchange column chromatography. Increased awareness about genetic testing for diagnosis of sickle cell anemia and other disorders is expected to contribute toward revenue growth in the near future. Genetic testing is an emerging cost-effective approach to reduce the pervasiveness of the disease.

Common therapies available are blood transfusion, bone marrow transplant, chelation therapy and hydroxyurea. Higher capital & reagent costs and inadequate required skills and experience for interpreting the results due to data complexity are among major restraints.

To access sample pages or view this report titled, “Hemoglobinopathies Market Size, Industry Analysis Report, Regional Outlook (U.S., Germany, UK, Italy, Russia, China, India, Japan, South Korea, Brazil, Mexico, Saudi Arabia, UAE, South Africa), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023” in detail along with the table of contents, please click on the link below:

Globally, incidence of thalassemia is about 0.2 million patients, whereas sickle cell anemia has higher occurrence of around 20 million. Due to unawareness about disease, death to survival ratio for the patients has increased. However, increased government and private organizations initiatives for spreading awareness about hemoglobin diseases are expected to drive hemoglobinopathies market growth over the forecast period. Advanced diagnostics and therapeutics will likely fuel industry growth in the coming years. In 2010, the Centers for Disease Control (CDC) in collaboration with National Heart, Lung and Blood Institute established the Registry and Surveillance System for Hemoglobinopathies (RuSH) project for collecting initial state-specific information about people with sickle cell disease and thalassemia.

The industry is divided into sickle cell diseases, thalassemia (alpha and beta), and other disorders such as hereditary elliptocytosis. Mutations in gene encoding for globins generate different hereditary disorders, leading to blood diseases such as sickle cell disease and thalassemia. Sickle cell anemia disease and thalassemia diagnostics and therapeutic market are expected to exhibit growth over the forecast timeframe due to increase in patient awareness about the disorders and consequent progress in diagnosis and treatment.

In 2015, North America was the largest revenue generating region with around USD 1.2 billion owing to rise in R&D investments, better compensation state, and presence of high quality healthcare infrastructure. Asia Pacific hemoglobinopathies market share is anticipated to increase at 9% CAGR due to rising patient awareness and introduction of manufactured and low cost diagnostic kits. Sickle cell anemia is the most prevalentdisease in West Africa, with nearly 20% of people having sickle cell trait and about 2% of total babies born with a form of the disease. In many regions of Europe, hemoglobin (Hb) disorders are classified as prevalent diseases.

Make an inquiry for buying this report @

In the U.S., nearly 1,000 babies are born with sickle cell diseases every year. Increasing pervasiveness of several hemoglobinopathy disorders and high level of awareness about related genetic testing has boosted regional growth. The disease does not have a permanent treatment resulting in growing demand for novel products in the pharmaceutical industry.

Key industry players comprise Alnylam Pharmaceuticals, Gamida Cell, Biogen Idec, AcceleronPharma, Sangamo BioSciences, Anthera Pharmaceuticals, Global Blood Therapeutics, Genetix Pharmaceuticals, Mast Therapeutics, Prolong Pharmaceuticals, Emmaus Medical, Calgene Corporation, Invenux, Optinova Ab, and HemaQuest Pharmaceuticals. Companies are aiming on the partnership and licensing deals for sharing the research and development platform. In 2014, Sangamo BioSciences and Biogen Idec declared collaboration agreement that targeted hemoglobinopathies market therapeutics development.

Browse Related Reports:

• Blood Preparation Market Size By Product (Whole Blood, Blood Components, Blood Derivatives), By Application (Thrombocytosis, Pulmonary Embolism, Renal Impairment, Angina Blood Vessel Complications), By Antithrombotic and Anticoagulants (Platelet Aggregation Inhibitors, Fibrinolytics, Anticoagulants), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, China, Japan, Brazil, Mexico, South Africa), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hemoglobinopathies Market – Industry Analysis, Share, Research Report 2023 here

News-ID: 475753 • Views: 408

More Releases from Global Market Insights, Inc.

Strontium Market to see 6% CAGR till 2024 | Solvay, BassTech, Prochem, Chemalloy …
Global Market Insights, Inc. says that strontium market will reach USD 650 million by 2025. However, strong government regulations regarding air pollution may hinder market growth over the forecast timeframe. Based on product segment, the strontium carbonate segment was reported to hold over 55% of the total market share in 2017. The product is extensively used in the production of flares and fireworks. Strontium carbonate is a tasteless and odorless white
Silver nanoparticles market to grow at 12% CAGR till 2024 | Top Vendors are Amer …
Rising preference for packaged food and proliferating demand for ready-to-eat products will drive the industry expansion. It is estimated that the food & beverage application segment will contribute over USD 300 million towards silver nanoparticles market share by 2024. With metal nanoparticles setting the trend in a slew of consumer goods, such as textiles, food, pastes and soaps, silver nanoparticles have gained popularity owing to its chemical, physical and biological attributes.
COVID-19 to Impact Demand Growth of Erdosteine Market | Top Key Players are Reci …
Global Market Insights, Inc. says that the erdosteine market could surpass USD 160 million by 2025. Driven by growing occurrences of common respiratory issues like cold, bronchitis, and cough, the global erdosteine market is estimated to observe significant profits through 2025. Erdosteine has a broad range of applications in the production of drugs to ameliorate and control the symptoms that arise due to excessive mucus production, which is likely to
Hydrophobing Agents Market to gain significant revenue by 2026
Global Market Insights, Inc says that Global Hydrophobing agents market share to cross USD 1.6 billion by 2026. Driven by increasing dispersion in the construction and buildings sector, the hydrophobing agents market is projected to witness massive gains through 2026. Apart from the construction sector, the use of these chemicals in personal care industries would push its demand over the forthcoming years. The hydrophobing agents are occlusive in nature, blocking lacerations

All 5 Releases

More Releases for Blood

Blood Donation Chair
Blood Donation Chair Size: 190 L * 92 W * 135 - 164 H cm Back plate, the angle of inclination of the leg plate. Height adjustment. The adjustments are all electrically controlled and easy to operate. This product comes with three LINAK motors Maximum load capacity: 240 kg Optional: CPR function, weighing function The marketplace was wholly developed by the Jiangsu Medwish Network Technology Co., Ltd., a private corporation based in Jiangsu,
Blood Group Typing Market Banks on Increasing Need for Blood, Blood Products, an …
The global blood group typing market is foreseen to garner a massive demand in the foreseeable future owing to certain factors such as the rising demand for blood and blood products. Nonetheless, the market growth could see an escalation on the back of other factors such as increasing prenatal testing which requires blood grouping, mounting count of road mishaps and trauma incidences requiring blood transfusion, and increasing application in forensic
Artificial Blood Market Development
Artificial Blood Market Potential According to the World Health Organization (WHO), there are around 50,000 stem cell transplantations performed annually worldwide, which include 2,000 cord blood hematopoietic stem cell transplants performed each year. Use of stem cells from cord blood is increasing, as it does not require perfect human leukocyte antigen (HLA) tissue matching, can be used allogenically, and has less incidence of graft v/s host disease. According to the New
Blood Group Typing Market Banks on Increasing Need for Blood, Blood Products, an …
The global blood group typing market is foreseen to garner a massive demand in the foreseeable future owing to certain factors such as the rising demand for blood and blood products. Nonetheless, the market growth could see an escalation on the back of other factors such as increasing prenatal testing which requires blood grouping, mounting count of road mishaps and trauma incidences requiring blood transfusion, and increasing application in forensic
Blood Bank Market 2017 has announced the addition of the “Global Blood Bank Market Research Report 2017” The report focuses on global major leading industry players with information such as company profiles, product picture and specification. Blood Bank industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and
Artificial Blood Market
Artificial blood is an artificially developed substitute for red blood cells. For decades, scientists have been trying to develop artificial blood from various sources and through different methods to address the shortage of blood for transfusions. Inadequate number of blood donors and the criticality of blood-type rejection have encouraged researchers to develop artificial blood, thus reducing the dependency on blood donors. Transfusion of red blood cells (RBCs) is a standard